Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABIVAX Société AnonymeADS(ABVX) | 2,349,443 | 3,960,000 | +1,610,557 | $313.09M | $392.12M | 10.13% | +$79.03M |
| Neurocrine Biosciences, Inc.(NBIX) | 1,880,000 | 2,500,000 | +620,000 | $316.85M | $354.60M | 9.16% | +$37.75M |
| BioMarin Pharmaceutical Inc.(BMRN) | 6,025,000 | 5,525,000 | -500,000 | $344.75M | $331.50M | 8.56% | -$13.25M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 1,575,000 | 4,815,000 | +3,240,000 | $128.38M | $315.14M | 8.14% | +$186.76M |
| Insmed Incorporated(INSM) | 250,000 | 2,725,000 | +2,475,000 | $26.66M | $311.03M | 8.04% | +$284.38M |
| United Therapeutics Corporation(UTHR) | 435,000 | 475,000 | +40,000 | $235.70M | $257.40M | 6.65% | +$21.70M |
| Ascendis Pharma A/S(ASND) | 375,000 | 740,000 | +365,000 | $100.02M | $168.59M | 4.36% | +$68.57M |
| Nurix Therapeutics, Inc.(NRIX) | 8,050,000 | 7,025,000 | -1,025,000 | $195.29M | $166.56M | 4.30% | -$28.73M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 1,050,000 | 2,033,625 | +983,625 | $66.09M | $159.86M | 4.13% | +$93.78M |
| Enliven Therapeutics Inc | 4,000,000 | 3,225,000 | -775,000 | $203.00M | $147.83M | 3.82% | -$55.17M |
| Disc Medicine, Inc.(IRON) | 1,550,000 | 1,635,000 | +85,000 | $113.37M | $107.03M | 2.77% | -$6.34M |
| Bicara Therapeutics Inc | 5,250,000 | 5,525,000 | +275,000 | $155.87M | $102.82M | 2.66% | -$53.05M |
| Dyne Therapeutics, Inc.(DYN) | 3,375,000 | 6,200,000 | +2,825,000 | $74.96M | $99.88M | 2.58% | +$24.92M |
| Immatics N.V.SHS(IMTX) | 6,175,000 | 11,200,000 | +5,025,000 | $62.55M | $98.34M | 2.54% | +$35.78M |
| Taysha Gene Therapies, Inc.(TSHA) | 19,415,000 | 18,045,000 | -1,370,000 | $132.22M | $87.88M | 2.27% | -$44.34M |
| Monte Rosa Therapeutics Inc | 4,600,000 | 7,130,000 | +2,530,000 | $111.32M | $85.06M | 2.20% | -$26.26M |
| Globus Medical, Inc.CL A(GMED) | 850,000 | 915,000 | +65,000 | $67.16M | $68.53M | 1.77% | +$1.38M |
| Crescent Biopharma Inc | 1,630,000 | 3,000,000 | +1,370,000 | $29.34M | $43.77M | 1.13% | +$14.43M |
| Zimmer Biomet Holdings, Inc.(ZBH) | 1,400,000 | 475,000 | -925,000 | $120.53M | $42.19M | 1.09% | -$78.33M |
| Travere Therapeutics, Inc.(TVTX) | 0 | 600,000 | +600,000 | $0 | $35.33M | 0.91% | +$35.33M |
| Arcus Biosciences, Inc.(RCUS) | 0 | 1,300,000 | +1,300,000 | $0 | $33.58M | 0.87% | +$33.58M |
| Xenon Pharmaceuticals Inc.(XENE) | 700,000 | 850,000 | +150,000 | $42.25M | $31.61M | 0.82% | -$10.64M |
| Nektar Therapeutics(NKTR) | 1,000,000 | 510,000 | -490,000 | $69.81M | $30.88M | 0.80% | -$38.93M |
| Bright Minds Biosciences Inc | 545,000 | 545,000 | 0 | $38.26M | $27.15M | 0.70% | -$11.11M |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 400,000 | +400,000 | $0 | $26.32M | 0.68% | +$26.32M |
| Immunocore Holdings plcADS(IMCR) | 1,800,000 | 850,000 | -950,000 | $57.15M | $25.75M | 0.67% | -$31.40M |
| Insulet Corporation(PODD) | 670,000 | 175,000 | -495,000 | $102.01M | $22.83M | 0.59% | -$79.18M |
| Trevi Therapeutics, Inc.(TRVI) | 3,100,000 | 1,495,000 | -1,605,000 | $57.81M | $21.41M | 0.55% | -$36.41M |
| SanofiADR(SNY) | 2,000,000 | 500,000 | -1,500,000 | $85.32M | $20.61M | 0.53% | -$64.70M |
| Savara Inc.(SVRA) | 2,720,000 | 3,300,000 | +580,000 | $16.76M | $17.03M | 0.44% | +$272.8K |
| SpyGlass Pharma, Inc.(SGP) | 670,000 | 640,000 | -30,000 | $14.91M | $16.64M | 0.43% | +$1.73M |
| Zymeworks Inc.(ZYME) | 0 | 600,000 | +600,000 | $0 | $15.89M | 0.41% | +$15.89M |
| Cogent Biosciences, Inc.(COGT) | 0 | 475,000 | +475,000 | $0 | $15.21M | 0.39% | +$15.21M |
| Solid Biosciences Inc | 2,160,000 | 2,085,000 | -75,000 | $21.58M | $15.07M | 0.39% | -$6.50M |
| Lexeo Therapeutics Inc | 4,320,000 | 4,320,000 | 0 | $20.11M | $14.60M | 0.38% | -$5.51M |
| Avalo Therapeutics Inc | 775,000 | 800,000 | +25,000 | $14.32M | $12.26M | 0.32% | -$2.06M |
| Zenas BioPharma, Inc.(ZBIO) | 365,000 | 395,000 | +30,000 | $9.26M | $10.65M | 0.28% | +$1.39M |
| Evommune Inc | 1,000,000 | 1,250,000 | +250,000 | $13.29M | $10.32M | 0.27% | -$2.96M |
| Viking Therapeutics, Inc.(VKTX) | 680,000 | 290,000 | -390,000 | $26.53M | $9.45M | 0.24% | -$17.07M |
| Stoke Therapeutics, Inc.(STOK) | 0 | 345,000 | +345,000 | $0 | $8.97M | 0.23% | +$8.97M |
| Korsana Biosciences Inc | 0 | 263,105 | +263,105 | $0 | $8.42M | 0.22% | +$8.42M |
| Damora Therapeutics Inc | 0 | 395,000 | +395,000 | $0 | $8.41M | 0.22% | +$8.41M |
| Tectonic Therapeutic Inc | 425,000 | 360,000 | -65,000 | $14.61M | $8.38M | 0.22% | -$6.22M |
| Zura Bio LtdCL A | 1,173,956 | 1,860,000 | +686,044 | $6.93M | $7.74M | 0.20% | +$811.3K |
| Glaukos Corporation(GKOS) | 0 | 45,000 | +45,000 | $0 | $7.39M | 0.19% | +$7.39M |
| Kailera Therapeutics Inc | 575,000 | 625,000 | +50,000 | $12.67M | $7.14M | 0.18% | -$5.53M |
| Anteris Technologies Global Co | 1,010,000 | 850,000 | -160,000 | $9.95M | $6.60M | 0.17% | -$3.34M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 525,000 | +525,000 | $0 | $6.14M | 0.16% | +$6.14M |
| Rezolute Inc | 382,999 | 1,455,000 | +1,072,001 | $1.99M | $6.02M | 0.16% | +$4.03M |
| First Tracks Biotherapeutics I | 1,013,000 | 169,738 | -843,262 | $20.38M | $6.02M | 0.16% | -$14.37M |
| Voyager Therapeutics Inc | 2,625,000 | 2,165,000 | -460,000 | $9.19M | $5.80M | 0.15% | -$3.39M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 175,000 | +175,000 | $0 | $4.76M | 0.12% | +$4.76M |
| Olema Pharmaceuticals Inc | 418,551 | 420,000 | +1,449 | $5.24M | $3.63M | 0.09% | -$1.61M |
| Palisade Bio Inc | 2,500,000 | 2,500,000 | 0 | $5.22M | $3.38M | 0.09% | -$1.85M |
| enGene Therapeutics Inc | 1,667,430 | 1,665,000 | -2,430 | $2.88M | $3.33M | 0.09% | +$445.3K |
| Neurogene Inc | 0 | 115,000 | +115,000 | $0 | $3.20M | 0.08% | +$3.20M |
| iBio Inc | 2,600,000 | 2,600,000 | 0 | $4.55M | $3.07M | 0.08% | -$1.48M |
| ArriVent Biopharma Inc | 0 | 100,000 | +100,000 | $0 | $3.03M | 0.08% | +$3.03M |
| OnKure Therapeutics IncCL A | 1,825,699 | 1,088,000 | -737,699 | $8.33M | $2.96M | 0.08% | -$5.36M |
| CytomX Therapeutics Inc | 0 | 535,000 | +535,000 | $0 | $1.46M | 0.04% | +$1.46M |
| Oculis Holding AG | 0 | 132,000 | +132,000 | $0 | $1.23M | 0.03% | +$1.23M |
| Nyxoah SASHS SHS | 843,461 | 479,000 | -364,461 | $1.43M | $661.0K | 0.02% | -$764.4K |
| Aprea Therapeutics Inc | 350,000 | 350,000 | 0 | $280.8K | $262.5K | 0.01% | -$18.3K |
| Abbott Laboratories | 1,400,000 | 0 | -1,400,000 | $127.04M | $0 | — | -$127.04M |
| Alcon Inc.(ALC) | 500,000 | 0 | -500,000 | $33.55M | $0 | — | -$33.55M |
| Alto Neuroscience, Inc.(ANRO) | 785,000 | 0 | -785,000 | $20.72M | $0 | — | -$20.72M |
| AstraZeneca PLC(AZN) | 450,000 | 0 | -450,000 | $85.33M | $0 | — | -$85.33M |
| Beta Bionics, Inc.(BBNX) | 1,600,000 | 0 | -1,600,000 | $25.07M | $0 | — | -$25.07M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 8,300,000 | 0 | -8,300,000 | $83.00M | $0 | — | -$83.00M |
| Bristol-Myers Squibb Company(BMY) | 800,000 | 0 | -800,000 | $46.10M | $0 | — | -$46.10M |
| Damora Therapeutics, Inc.(DMRA) | 575,000 | 0 | -575,000 | $14.96M | $0 | — | -$14.96M |
| GE HealthCare Technologies Inc.(GEHC) | 450,000 | 0 | -450,000 | $28.80M | $0 | — | -$28.80M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 65,000 | 0 | -65,000 | $34.90M | $0 | — | -$34.90M |
| Monopar Therapeutics Inc.(MNPR) | 75,727 | 0 | -75,727 | $7.01M | $0 | — | -$7.01M |
| Myriad Genetics, Inc.(MYGN) | 5,735,000 | 0 | -5,735,000 | $32.75M | $0 | — | -$32.75M |
| Rapport Therapeutics, Inc.(RAPP) | 730,000 | 0 | -730,000 | $30.42M | $0 | — | -$30.42M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 40,000 | 0 | -40,000 | $24.94M | $0 | — | -$24.94M |
| Repligen Corporation(RGEN) | 400,000 | 0 | -400,000 | $54.58M | $0 | — | -$54.58M |
| Revolution Medicines, Inc.(RVMD) | 450,000 | 0 | -450,000 | $84.28M | $0 | — | -$84.28M |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 535,452 | 0 | -535,452 | $4.14M | $0 | — | -$4.14M |
| Surrozen, Inc.(SRZN) | 304,669 | 0 | -304,669 | $7.91M | $0 | — | -$7.91M |
| Tenax Therapeutics, Inc.(TENX) | 53,439 | 0 | -53,439 | $777.5K | $0 | — | -$777.5K |
| uniQure N.V.SHS(QURE) | 935,000 | 0 | -935,000 | $43.07M | $0 | — | -$43.07M |